US controllers have sent a notice letter to Juul Labs, saying the e-cigarette organization damaged US law by advancing its items as more secure than conventional cigarettes.
The firm should have close down from the Food and Drug Administration (FDA) to make such a case.
The notice comes as authorities test a flare-up of destructive lung disease possibly connected to vaping items.
Juul said it was checking on the FDA concerns and will “completely coordinate”.
The organization, which has since quite a while ago advanced its nicotine units as a more secure option in contrast to customary cigarettes, must give a composed reaction to the FDA inside 15 days.
Acting FDA official Ned Sharpless said organizations must present logical proof before showcasing items as less hazardous than tobacco.
“Juul has disregarded the law, and in all respects concerningly, has owned a portion of these expressions in school to our country’s childhood,” he said.
Michigan a week ago turned into the main state in the US to boycott enhanced e-cigarettes.
The move came as the US Centers for Disease Control and Prevention (CDC) affirmed it was exploring five passings in California, Illinois, Indiana, Minnesota and Oregon related with utilization of vaping items.
Moreover, the office said it is analyzing in excess of 450 instances of lung ailments.
Juul: The ascent of a $38bn e-cigarette wonder
First demise connected to vaping announced in Illinois
Government authorities have been pushing Juul – the greatest player in the US e-cigarette advertise – to change its promoting since a year ago, in the midst of a surprising increment in youth vaping.
The firm has reacted by restricting on the web deals to anybody younger than 21, halting its web based life battles and suspending offers of its seasoned items in customary stores, among different advances.
Monday’s notice demonstrated that wellbeing authorities stay disappointed with the association’s response. The Federal Trade Commission, which controls business exercises, is likewise allegedly researching the company’s promoting.
“We trust you have a proceeding with obligation to make a move to address the pestilence of youth utilization of your items, some of which seems to have been an immediate consequence of your item plan and promoting efforts, regardless of whether a portion of these practices have been suspended,” the FDA composed.